Home > Insider Trading > Filing (0001179022-10-000061)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1010086	Siga Technologies Inc	SIGA	Pharmaceutical Preparations (2834)	133864870

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1275596	M M Adnan Mjalli	C/O Transtech Pharma, Inc. 4170 Mendenhall Oaks Parkway, Suite 110 High Point NC 27265		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share ("Common Stock")	Acquisiton	2009-09-30	1,845,396	$1.88	4,317,618	No	4	X	Indirect	by TransTech Pharma, Inc.
Common Stock	Disposition	2009-09-30	444,666	$7.80	3,872,952	No	4	F	Indirect	by TransTech Pharma, Inc.
Common Stock	Disposition	2009-09-30	3,851,969	$6.24	20,983	No	4	S	Indirect	by TransTech Pharma, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	by TransTech Pharma, Inc.
No	4	F	Indirect	by TransTech Pharma, Inc.
No	4	S	Indirect	by TransTech Pharma, Inc.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2009-09-30	1,845,396	$0.00	1,845,396	$1.88

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2004-01-08	2011-01-08	No	4	X	Indirect

Footnotes

On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.